Streetbeat News

Stock Prices

IGC

IGC Pharma shares rose following a Form 4 filing revealing that director James P. Moran acquired 588,235 shares at $0.34 each.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 8:15 pm

RPD

Rapid7 shares increased after Jana Partners disclosed a 5.8% stake in the company, as per a 13D filing.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 8:15 pm

RPD

Jana Partners has acquired a 5.8% stake in Rapid7, as revealed in a recent 13D filing. This indicates potential activist involvement, which could lead to strategic changes or influence in Rapid7's operations.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 8:14 pm

UDMY

Morgan Stanley analyst Josh Baer downgraded Udemy, Inc. (NASDAQ:UDMY) to Underweight, citing a negative risk/reward profile due to weak demand and strategic shifts. The price target was lowered to $7.50. Udemy's recent workforce changes and strategic focus may lead to disruptions.

Portfolio Pulse from Nabaparna Bhattacharya

September 27, 2024 | 8:13 pm

OM

Outset Medical Inc received a notice from Nasdaq on September 23 for failing to satisfy a continued listing rule or standard.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 8:12 pm

MIRA

MIRA Pharmaceuticals Inc. shares rose after announcing promising preclinical data for Ketamir-2, a novel oral Ketamine analog, showing 100% reversal of neuropathic pain. The company plans to submit an IND application to the FDA by December 2024 and aims for human trials by 2025.

Portfolio Pulse from Vaishali Prayag

September 27, 2024 | 8:12 pm

MET

MetLife (NYSE:MET) has been evaluated by 10 analysts over the past three months, with a mix of bullish and somewhat bullish ratings. The average 12-month price target has increased to $88.2, reflecting a positive sentiment. Analysts have adjusted their ratings and price targets, indicating a generally optimistic outlook for MetLife. Despite positive revenue growth, MetLife faces challenges with below-average net margin, ROE, and ROA, as well as a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 8:00 pm

MRVL

Marvell Tech (NASDAQ:MRVL) has outperformed the market over the past 5 years with an average annual return of 24.12%, surpassing the market by 9.84% annually. A $1000 investment in MRVL 5 years ago would now be worth $2,831.40.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 8:00 pm

UBER

Uber Technologies (NYSE:UBER) has outperformed the market over the past 5 years with an average annual return of 21.08%, surpassing the market by 6.8% annually. A $1000 investment in UBER 5 years ago would now be worth $2,489.99.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 8:00 pm

AEM

AU

CDE

NEM

WPM

Shares of precious metals companies are trading lower due to a pullback in gold and silver prices.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 7:57 pm